Search

everythinglearnresearchcommunity

for

Search:↓

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Using anabolic steroids 'Sus' and 'Deca' for bodybuilding caused severe acne in a man.

Sunflower oil was found to promote hair growth in mice with hormone-induced hair loss.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Tamoxifen caused hair loss in a 52-year-old woman.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Both mouse and rat models are effective for testing alopecia areata treatments.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Belimumab effectively controls SLE disease activity and reduces steroid use.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

No single biomarker is reliable enough for diagnosing and assessing SLE.